Drugs / DeepTag-GPRC5D Targeted CAR T-cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06084962 | Oct 2023 → Oct 2026 expected | refractory plasma cell neoplasm | He Huang | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DeepTag-GPRC5D Targeted CAR T-cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06084962 ↗ |
| Route | Intravenous | “by intravenous infusion” NCT06084962 ↗ |